Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
Status:
Withdrawn
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the non-inferiority clinical efficacy of two
different drug associations in the essential hypertension control.